SCHEMBL29888115

SCHEMBL29888115

C=C1CCN(c2ccc3ncnc(Nc4ccc(Cc5ccc(C)nc5)cc4)c3c2)C1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CD38 P28907 1/20 0.42
EIF2AK2 P19525 1/20 0.40
HTT P42858 3/20 0.39
MAPT P10636 3/20 0.39
MAPK1 P28482 2/20 0.39
AHR P35869 1/20 0.39
EGFR P00533 7/20 0.39
ERBB2 P04626 3/20 0.38
PIP4K2A P48426 2/20 0.37
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.36
NCOA1 Q15788 1/20 0.36
NCOA3 Q9Y6Q9 1/20 0.36
PIK3CA P42336 2/20 0.36
PIK3CG P48736 2/20 0.36
PIK3CD O00329 1/20 0.36
PIK3R1 P27986 1/20 0.36
PIK3CB P42338 1/20 0.36
GRM1 Q13255 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24569809 1.00 CD38 (0.42) CD38EIF2AK2HTTMAPTMAPK1
SCHEMBL24569380 0.82 EGFR (0.39) CD38EIF2AK2HTTMAPTMAPK1
SCHEMBL29888199 0.82 EGFR (0.39) CD38EIF2AK2HTTMAPTMAPK1
SCHEMBL24569295 0.81 ERBB2 (0.53) EGFRERBB2
SCHEMBL24569631 0.79 ERBB2 (0.41) CD38HTTMAPTEGFRERBB2
SCHEMBL29888120 0.79 ERBB2 (0.41) CD38HTTMAPTEGFRERBB2
SCHEMBL24167316 0.78 EGFR (0.57) HTTMAPTMAPK1EGFRERBB2
SCHEMBL29888804 0.76 EGFR (0.38) CD38EIF2AK2HTTMAPTMAPK1
SCHEMBL24569933 0.76 EGFR (0.38) CD38EIF2AK2HTTMAPTMAPK1
SCHEMBL24569912 0.76 KDM4E (0.58) HTTMAPTMAPK1AHREGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4267137-A1 LACTAM (HETERO)ARYLFUSEDPYRIMIDINE DERIVATIVES AS INHIBITORS OF ERBB2 Enliven Inc. (US) 2023-11-01 EP disclosed
WO-2022140769-A1 LACTAM (HETERO)ARYLFUSEDPYRIMIDINE DERIVATIVES AS INHIBITORS OF ERBB2 ENLIVEN THERAPEUTICS, INC. (US) 2022-06-30 WO disclosed